Good-Heart6425
Explorer
Eli Lilly opens early access to its next-gen obesity drug for a small group of patients#-eli-lilly-to-offer-early-access-to-next-gen-obesity-drug-to-some-patients
Source: Reuters, filed 03 Aug 2026 at 6:33 p.m. ET, by Sneha S K and Deena Beasley
In its 3 Aug report, Reuters said that on Monday the company (LLY) would let a limited number of patients get early access to retatrutide, its experimental obesity drug, ahead of U.S. FDA approval.
Source: Reuters, filed 03 Aug 2026 at 6:33 p.m. ET, by Sneha S K and Deena Beasley
In its 3 Aug report, Reuters said that on Monday the company (LLY) would let a limited number of patients get early access to retatrutide, its experimental obesity drug, ahead of U.S. FDA approval.